Last updated on May 2020

S-CEI of Nexium in Paediatric Patients


Brief description of study

To capture safety and efficacy when Nexium are administered to pediatric patients in clinical practice after launch

Detailed Study Description

The objective of this investigation is to capture the followings when Nexium capsules or Nexium granules for suspension (single-dose package) are administered to pediatric patients in clinical practice after launch.

  1. Development of adverse reactions which are unexpected from Precaution for Use
  2. Development of adverse reactions
  3. Efficacy

Clinical Study Identifier: NCT03562026

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.